2022年12月16日 智權新聞彙整

-

-

• 華為宣布與OPPO簽訂5G技術專利交叉授權 (聯合新聞網)
• Ericsson與蘋果簽署全球專利許可 5G無線專利糾紛和解 (聯合新聞網)

-

• 生物改良藥品(biobetter)崛起，不可忽視的製藥商機！ (Gene Online)

• 三星再簽專利交叉授權協議，轉讓美國 98 項專利給華為 (TechNews科技新報)
• 騰訊「立式刷掌設備」專利獲授權,身份識別不需露出臉部 (鉅亨網)
• 小米(01810)首部知識産權白皮書透露多個技術布局，累計全球授權專利超2.9萬項 (Investing)
• Tecnotree在美國完成CognitiveScale交易 (CNA訊息平台)

-

-

-

-

• ドコモ、レノボへ5Gなど特許技術をライセンス供与
• 知財高裁　エルデカルシトールカプセルの後発品特許侵害訴訟で控訴を棄却　沢井製薬と日医工が勝訴
• 東芝テックと寺岡精工、セミセルフレジに係る特許訴訟を和解解決

• A Look At The Upcoming European Unitary Patent And Unified Patent Court
• Huawei Suing Major US And EU Companies For Patent Infringement Of Its Wi-Fi/WLAN-Related Patents

• Huawei signs a patent cross-licensing agreement with its biggest Chinese rival
• Shimano files patent for app that can tell you when bike tyres and disc pads need replacing
• Samsung transfers some of its patents in the US to Huawei
• Microsoft Patent Shows Xbox Controller with LCD Display
• New license deal reached by Apple and Ericsson ends a patent feud that started in 2015
• Ericsson and Apple sign global patent license agreement
• Intel Asks Delaware Court to Dismiss $4 Billion VLSI Patent Suit
• GBT Filed a Continuation Application for its Facial and Body Recognition Patent
• Developments in Patent Disputes Between Apple and AliveCor
• Court swats down Vanda’s patent suit against Teva and Apotex, clearing the way for Hetlioz generics